Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bergmann

Showing results (141-150 of 206) with videos related to

Pageof 21
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 2024
Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in HumansMikael O W Piha, Kristiina Cajanus, Marica T Engström, et al.
Blood|September 3, 2009
Deferasirox pharmacokinetics in patients with adequate versus inadequate responseDeborah Chirnomas, Amber Lynn Smith, Jennifer Braunstein, et al.
Blood Advances|November 15, 2019
Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemiaDenis M Schewe, Lennart Lenk, Fotini Vogiatzi, et al.
International Journal of Cancer|September 30, 2023
Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patientsRabea Wagener, Danielle Brandes, Marie Jung, et al.
Clinical Drug Investigation|September 26, 2015
Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipientsTroels K Bergmann, Nicole M Isbel, Remo Ostini, et al.
Basic & Clinical Pharmacology & Toxicology|September 30, 2011
Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancerTroels K Bergmann, Charlotte Brasch-Andersen, Henrik Gréen, et al.
European Journal of Clinical Pharmacology|February 18, 2011
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancerTroels K Bergmann, Henrik Gréen, Charlotte Brasch-Andersen, et al.
Frontiers in Pediatrics|December 8, 2025
Low lymphozyte pool, colon perforation and hydrocephalus as clinical features in an infant with a postzygotic <i>PIK3CA</i> variantXimena Léon-Lara, Sarina Ravens, Sandra von Hardenberg, et al.
Diseases (Basel, Switzerland)|April 17, 2019
Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2)Georgios Sogkas, Natalia Dubrowinskaja, Anke K Bergmann, et al.
Brain : a Journal of Neurology|November 4, 2020
Rational therapy with vigabatrin and a ketogenic diet in a patient with GAD1 deficiencySandra von Hardenberg, Manuela F Richter, Sven Hethey, et al.
Pageof 21

Showing results (141-150 of 206) with videos related to

Sort By:
Pageof 21
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 2024
Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in HumansMikael O W Piha, Kristiina Cajanus, Marica T Engström, et al.
Blood|September 3, 2009
Deferasirox pharmacokinetics in patients with adequate versus inadequate responseDeborah Chirnomas, Amber Lynn Smith, Jennifer Braunstein, et al.
Blood Advances|November 15, 2019
Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemiaDenis M Schewe, Lennart Lenk, Fotini Vogiatzi, et al.
International Journal of Cancer|September 30, 2023
Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patientsRabea Wagener, Danielle Brandes, Marie Jung, et al.
Clinical Drug Investigation|September 26, 2015
Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipientsTroels K Bergmann, Nicole M Isbel, Remo Ostini, et al.
Basic & Clinical Pharmacology & Toxicology|September 30, 2011
Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancerTroels K Bergmann, Charlotte Brasch-Andersen, Henrik Gréen, et al.
European Journal of Clinical Pharmacology|February 18, 2011
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancerTroels K Bergmann, Henrik Gréen, Charlotte Brasch-Andersen, et al.
Frontiers in Pediatrics|December 8, 2025
Low lymphozyte pool, colon perforation and hydrocephalus as clinical features in an infant with a postzygotic <i>PIK3CA</i> variantXimena Léon-Lara, Sarina Ravens, Sandra von Hardenberg, et al.
Diseases (Basel, Switzerland)|April 17, 2019
Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2)Georgios Sogkas, Natalia Dubrowinskaja, Anke K Bergmann, et al.
Brain : a Journal of Neurology|November 4, 2020
Rational therapy with vigabatrin and a ketogenic diet in a patient with GAD1 deficiencySandra von Hardenberg, Manuela F Richter, Sven Hethey, et al.
Pageof 21